www.fiercepharma.com:
Blow up your sales force... or at least consider it. That's the message today from Deloitte Consulting, which has analyzed pharma sales and come up with some conclusions designed to provoke thought (and no doubt media coverag (Read More)
The IN VIVO Blog:
The Obama administration may have sent a subtle message to drug manufacturers Monday, when it nominated Julie Brill to be one of two new commissioners at the Federal Trade Commission. The message? Make sure your marketing pra (Read More)
www.fiercepharma.com:
Last week's two-day hearing on online drug marketing and social media was definitely a marathon, both in time logged and words entered into the record. Ideas flew from online providers and drugmakers and consumer advocates al (Read More)
Pharma Marketing Blog:
In his closing remarks at yesterday's public hearing on FDA regulation of social media, Tom Abrams, Director of FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC), said "what we have heard is it's a dif (Read More)
Pharma Marketing Blog:
In my presentation before the FDA at yesterday's public hearing, I made some specific suggestions, including the use of an FDA-designated hash tag to be included in each branded Tweet posted by pharmaceutical companies. If ea (Read More)
MSNBC:
Drugmakers, Internet companies and nonprofits packed a hearing Thursday into what is a gray area for U.S. health regulators: how far social media can go in promoting drugs. (Read More)
www.fiercepharma.com:
It looks as if yet another U.S. drug-marketing investigation is about to be settled. As Dow Jones reports, Forest Laboratories has reached a tentative deal with the feds, which would settle civil allegations that it mismarket (Read More)
Pharma Marketing Blog:
Only the following 13 FDA panel members will be able to ask questions during this week's public hearing on the use of social media by the pharmaceutical industry:Thomas W. Abrams - Director, Division of Drug Marketing, Advert (Read More)
www.fiercepharma.com:
Think Big Pharma has been plagued by whistleblower lawsuits lately? You ain't seen nothin' yet, legal eagles say. Yes, 2009 appears to be the year of the False Claims Act, that federal law that allows whistleblowers to sue--a (Read More)
www.fiercepharma.com:
Eli Lilly is catching heat for paying CVS Caremark to promote its Cymbalta drug to doctors. The CVS pharmacy benefits manager has been sending promotional materials to doctors, touting Cymbalta for its new indication as a fib (Read More)
Wall Street Journal:
SAN FRANCISCO (MarketWatch) -- Pharmacia & Upjohn Co., a subsidiary of Pfizer Inc. , was sentenced to pay the largest criminal fine ever imposed in the United States, the Department of Justice said late Friday. Pharmacia & Up (Read More)
The Pharma Compliance Blog: Your Space. For Your Space.:
By Judy Fox, CIS Senior Compliance Managerjudyfox@cis-partners.comNotice of Public Hearing on Advisability of Requiring Disclosure of Free Samplesof Prescribed Products given to Vermont Health Care Providers Date of hearing: (Read More)
Google News - Health:
Los Angeles TimesBotox Maker's Suit Cites Free SpeechNew York TimesIn an attack on the regulation of drug marketing, the makers of the antiwrinkle shot Botox have filed a free-speech lawsuit against the federal government. In (Read More)
The IN VIVO Blog:
There's no time this week for snark or clever themes, since the IVB team is also busy pulling together the October issues of START-UP and IN VIVO. (You can rail all you want in the comments section about our slacker attitude. (Read More)
USATODAY.com Health - Top Stories:
Allergan, the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying ...
. (Read More)
MSNBC:
Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech. (Read More)
USATODAY.com Money - Top Stories:
Allergan Inc., which makes the Botox wrinkle treatment, is challenging the government's ban on off-label drug marketing to doctors, ...
. (Read More)
World of DTC Marketing:
Facebook plans to announce a deal with online measurement company Nielsen Co., in a step to address advertisers' frustration with measuring how ads perform on the social network. Under the partnership, Facebook will begin (Read More)
World of DTC Marketing:
Here are some thought provoking findings to ponder.• If you lower bad cholesterol (LDL) but have a low HDL (good cholesterol) there is no benefit to statins. (i)• If you lower bad cholesterol (LDL) but don't reduce inflammati (Read More)
Pharma Marketing Blog:
On April 1, 2009, my "April Fool's" joke press release announcing that the FDA issued draft guidance for use of social media for Rx drug marketing created quite a stir among pharmaceutical industry pundits and executives (see (Read More)